Trial Profile
Metabolic effects of valproate and antipsychotic therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary) ; Valproic acid
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacodynamics
- 28 Jan 2020 Status changed from recruiting to completed.
- 20 Nov 2005 New trial record.